April 16, 2021 10:30 am ETEstimated Read Time: 5 Minutes
The 2020 election saw several states legalize cannabis along with a handful of others who’ve legalized in 2021. Legal access in the form of medical and/or retail cannabis is now available to residents in more states than not in our country, including our nation’s capital Washington D.C. On the precipice of the doorstep of change, cannabis legalization could be turning over a new leaf on a federal level.
Medical cannabis and adult retail cannabis have a great chance of being legalized across the entire United States in the not too distant future. Some people have questions about this. Questions like why do you need medical cannabis if adult-use recreational cannabis is legal and anyone can purchase it? Is there really a need then for citizens to receive medical cannabis recommendations from physicians in order to go to dispensaries? Can’t they just walk in and buy the cannabis they need like everyone else? There are questions like these and many more.
A change in federal law would open the doors for insurance companies to cover medical cannabis expenses the way they would other prescriptions. More people would be willing to work with cannabis because of the lack of fear of prosecution. Many people in a professional line of work have put in many hours of school to get where they are as well as countless amounts of money to pay for that schooling. Most of them are not willing to risk losing their jobs or credibility over cannabis. However, if cannabis were legal, it would open doors into the industry for those who don’t even consume the plant.
If insurers were to cover medical cannabis, the market would be unpredictably large. Cannabis has worked for many as an alternative for opioids and other forms of addiction. It has the potential to stand as a natural alternative to Suboxone, methadone, and other forms of controversial medications used to treat dependence. Both the retail adult-use cannabis market and the medical cannabis market would have a chance to show what they’re capable of with full legalization.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
A Look at Industry Stats and Legislation
Predictions put a combination of the retail and medical cannabis markets somewhere near $15 billion approaching the end of 2020 in the United States. New Frontier Data released projections suggesting that retail cannabis would increase from $13.2 billion dollars as of 2019 to roughly $35 billion by 2025. In 2020 alone, cannabis saw over $18 billion in sales.
The surge of support for the legal cannabis industry has pushed Congress to discuss full spread cannabis legalization for all of America. This past December, the US federal government discussed the MORE Act. The MORE Act would’ve worked to decriminalize cannabis on a federal level as well as expunged the convictions of non-violent cannabis offenses. This Act was originally set to have a vote in September of 2020 but became delayed because of COVID-19 relief efforts and eventually died in the Senate after it passed the House vote. However, the bill is set to be reintroduced this year along with a new SAFE Banking Act which also did not get past the republican controlled Senate last year.
In a letter to colleagues dated on Nov 9, 2020, House majority leader Steny Hoyer said, “The house will vote on the MORE Act to decriminalize cannabis and expunge convictions for non-violent cannabis offenses that have prevented many Americans from getting jobs, applying for credit and loans, and accessing opportunities that make it possible to get ahead in our economy.” The Cannabis Caucus co-chair representative Barbara Lee said, “We’re going to continue building momentum so that Congress takes action to end the failed prohibition of cannabis before the year is out period too much is at stake for communities of color.”
Despite the failed results of these bills in previous years, the attempts are still incredibly significant in the effect that they are paving the road for legalization. As the years go on, more and more people are supporting cannabis and have no moral issue with it. Cannabis legalization is inevitable, it’s just a matter of when and how.
So, Will the Medical Market Survive?
Will the medical cannabis market survive full-on federal legalization? The answer to that question cannot be answered until federal legalization occurs and we see just what kind of regulations they have in store for any markets thereafter.
Ashley Priest is a patient, mother, entrepreneur, and activist that fights to end prohibition globally for a better future for all. Ashley has a passion for sharing education pertaining to the goddess plant known as cannabis. She believes that a single seed can tip the scales and that together through education we can end the stigma that is preventing cannabis from flowering to its full potential globally.
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or “magic” mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migraines—particularly when microdosing. It’s not just liberty caps anymore, folks. There are many different varieties and types…
Edibles are arguably one of the best means of recreational cannabis consumption—you get to eat a treat AND experience a long-lasting high. But it’s easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
According to a new study published by the University of New Mexico (UNM) in the prestigious journal Frontiers in Pharmacology, researchers have unveiled a significant correlation between the sensation of “feeling high” and the relief of medical symptoms among cannabis patients. This landmark study probes uncharted territories, challenging pre-existing assumptions and opening new avenues for…
A survey illustrates psychedelics’ rapid rise, Herer Brands sues Daniel Herer, and Hulkamania comes to cannabis. Let’s dive into this week’s canna-news. Psychedelic Use Reaches Record High A new national survey conducted by Monitoring The Future found that psychedelic use is at an all-time high amongst U.S. adults. Conducted in 2022, the survey included approximately…
We use our own as well as third party cookies to improve your site experience and the services we make available. You can learn more about our use of cookies in our Privacy Policy.
Content Disclamer
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.